 ?您的位置：對(duì)照品 > 標(biāo)準(zhǔn)物質(zhì) > 環(huán)保部標(biāo)準(zhǔn)物質(zhì) > |
|
|
|
| 產(chǎn)品基本信息 |
|
| 產(chǎn)品編號(hào)：O170000 |
| 產(chǎn)品名稱(chēng)：Oclacitinib |
| 產(chǎn)品CAS：1208319-26-9 |
| 規(guī)格含量：5mg |
| 產(chǎn)品價(jià)格：面議 |
| 聯(lián)系我們: |
 |
|
 |
|
|
| 產(chǎn)品詳細(xì)介紹 |
| 標(biāo)準(zhǔn)品編號(hào): |
O170000 |
| 名稱(chēng): |
Oclacitinib |
| 別名: |
trans-N-Methyl-4-(methyl-7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)cyclohexanemethanesulfonamide; JAKi; PF 03394197 |
| CAS號(hào): |
1208319-26-9 |
| 分子式: |
C??H??N?O?S |
| 外觀: |
白色至淡黃色固體 |
| 熔點(diǎn): |
226-228°C |
| 分子量: |
337.44 |
| 儲(chǔ)存: |
冰箱, under inert atmosphere |
| 溶解度: |
DMSO (Slightly), Methanol (Slightly, Heated) |
| 類(lèi)別: |
Standards; Enzyme Activators and Inhibitors; Pharmaceutical/API Drug Impurities/Metabolites; |
| 應(yīng)用: |
Oclacitinib is a novel Janus kinase (JAK) inhibitor with activity against cytokines involved in allergy. |
| 參考文獻(xiàn) |
|
|
|
|
|
|
|
|
